Hydroxytoluic acid

CAS No. 83-40-9

Hydroxytoluic acid( Hydroxytoluic acid | NSC 17561 | NSC17561 | NSC-17561 )

Catalog No. M16090 CAS No. 83-40-9

The salts or esters of salicylic acids, or salicylate esters of an organic acid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
500MG 35 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hydroxytoluic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    The salts or esters of salicylic acids, or salicylate esters of an organic acid.
  • Description
    The salts or esters of salicylic acids, or salicylate esters of an organic acid. Some of these have analgesic, antipyretic, and anti-inflammatory activities by inhibiting prostaglandin synthesis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Hydroxytoluic acid | NSC 17561 | NSC17561 | NSC-17561
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    83-40-9
  • Formula Weight
    152.15
  • Molecular Formula
    C8H8O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM
  • SMILES
    CC1=C(O)C(C(O)=O)=CC=C1
  • Chemical Name
    2,3-Cresotic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Cummings AJ, Martin BK. Br J Pharmacol ChemOthers. 1965 Oct;25(2):470-80.
molnova catalog
related products
  • Salicoside

    Salicin is a phenol β-glycosid produced from willow bark that shows anti-inflammatory effects.

  • Amfenac Sodium Monoh...

    Amfenac Sodium monohydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety.

  • Etoricoxib

    Etoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood).